Endpoints News· @endpts · X·· 6 天前AI 评分42
AI 导读
VectorY为其A轮融资追加8350万美元,用于资助一种基因疗法,该疗法可在脑内产生针对ALS相关蛋白的抗体。https://endpoints.news/vectory-bags-83-5m-for-antibody-gene-therapies-in-neurodegenerative-diseases/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
正文
VectorY added $83.5M to its Series A to fund a gene therapy that makes antibodies against ALS-linked proteins in the brain. https://endpoints.news/vectory-bags-83-5m-for-antibody-gene-therapies-in-neurodegenerative-diseases/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源:Endpoints News · x.com